期刊文献+

14-3-3蛋白在人脑胶质瘤中的表达及生物学意义(英文) 被引量:4

Expression and biological significance of 14-3-3 in gliomas
下载PDF
导出
摘要 目的检测14-3-3蛋白在人脑胶质瘤中的表达情况,探讨其在胶质瘤发生发展中的生物学意义。方法采用免疫组化亲和素-生物素过氧化物酶复合物(ABC)法检测5个胶质瘤细胞系(U251MG,U87MG,BT325,SHG44和C6)、121例人脑胶质瘤石蜡标本和10例正常脑组织中14-3-3蛋白的表达情况。分析14-3-3蛋白的表达在胶质瘤发生发展中的作用。结果在正常脑组织标本中,13-3-3蛋白主要表达于神经元的胞体和突起,仅在少数的胶质细胞中可见14-3-3蛋白的弱表达。然而,5个胶质瘤细胞系和绝大部分星形细胞瘤中可见14-3-3蛋白的阳性表达,其表达阳性率为:Ⅰ级78.6%(11/14),II级75%(18/24),III级76.2%(16/21),IV级80%(20/25)。不同恶性级别的星形细胞瘤中,14-3-3蛋白的阳性表达率无显著差别,但14-3-3蛋白的表达强度和范围有随肿瘤的恶性度增高而增加的趋势。其它类型的胶质瘤中也可见14-3-3蛋白的大量表达,其表达阳性率为:少突胶质细胞瘤66.7%(4/6),间变型少突胶质细胞瘤100%(4/4),室管膜瘤50%(2/4),间变型室管膜瘤66.7%(2/3),脉络从乳头状瘤100%(5/5),松果体细胞瘤100%(3/3),髓母细胞瘤66.7%(8/12)。结论14-3-3蛋白在人脑胶质瘤中有大量的表达。14-3-3蛋白表达上调可能是胶质瘤细胞对抗调亡的一种共同机制,以14-3-3蛋白为靶点有望成为一种有前景的新的胶质瘤生物学治疗方法。 Objective To investigate the expression and its biological significance of 14-3-3 proteins in human gliomas. Methods The expression of 14-3-3 proteins was detected in five glioma cell lines (U251MG, U87MG, BT325, SHG44, and C6), 121 eases of formalin-fixed, paraffin embedded archival tumor tissue from patients with glioma, and 10 normal human brain tissues by immunohistochemical avidin-biotin-peroxidase complex (ABC) method. And the biological significance of 14-3-3 proteins expression was analyzed in the etiopathogenesis of glioma. Results In the normal control brains, 14-3-3 immunoreactivity was localized mainly in the neuronal sormta and processes, and some glial cells showed only weak immunoreactivity. However, 14-3-3 immunoreactivity was seen in all of the five glioma cell lines and the majority of astrocytomas [78.6% in grade Ⅰ (11/14), 75% in grade Ⅱ (18/ 24), 76.2% in grade Ⅲ (16/21), and 80% in grade Ⅳ (20/25)]. No differences were found among the positive expression rates of 14-3-3 in different grades of astrocytomas. But the intensity and the degree of 14-3-3 expression showed trends with tumor grade. The 14-3-3 immunoreactivity was also seen in the majority of other gliomas [66. 7% in oligodendroglioma (4/6), 100% in anaplastic oligodendroglioma (4/4), 50% in ependymoma (2,/4), 66. 7% in anaplastic ependymoma (2,/3), 100% in choroid plexus papilloma (5/5), 100% in pineocytoma (3/3), and 66.7% in medulloblastoma (8/12) ].Conclusion Most human gliomas are positive for 14-3-3 proteins in this research. For most human gliomas, one common mechanism for escaping apoptosis may he the up-regulated expression of 14-3-3, and targeting 14-3-3 may he a novel promising strategy for the treatment of gliomas.
出处 《中华神经外科疾病研究杂志》 CAS 2006年第4期292-298,共7页 Chinese Journal of Neurosurgical Disease Research
基金 SupportedbytheNationalNaturalScienceFoundationofChina(39970752)
关键词 14—3-3蛋白 凋亡 免疫组化 胶质瘤 14-3-3 proteins Apoptosis Immunohistochemistry Glioma
  • 相关文献

参考文献16

  • 1DeAngelis LM. Brain tumors [J]. N Engl J Med, 2001,344(2) : 114- 123.
  • 2Wechsler-Reya R, Scott MP. The developmental biology of brain tumors [J]. Annu Rev Neurosci, 2001, 24:385 -428.
  • 3van Hemert M J, Steensma HY, van Heusden GP. 14-3-3 proteins: key regulators of cell division, ocalizat and apoptosis [ J ]. Bioessays,2001, 23(10): 936-946.
  • 4Rubio MP, Geraghty KM, Wong BH, et al. 14-3-3-Affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation, and trafficking [ J].Biochem J, 2004, 379(Pt 2) : 395 -408.
  • 5Hermeking H. The 14-3-3 cancer connection [ J]. Nat Rev Cancer,2003, 3(12) : 931 -943.
  • 6Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system [ J]. J Neuropathol Exp Neurol, 2002, 61(3): 215-225.
  • 7Kawamoto Y, Akiguchi 1, Nakamura S, et al. 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains [J].J Neuropathol Exp Neurol, 2002, 61 (3) : 245 -253.
  • 8Kawamoto Y, Akiguchi I, Nakamura S, et al. Accumulation of 14-3-3 proteins in glial cytoplasmic inclusions in multiple system atrophy [ J ].Ann Neurol, 2002, 52(6) : 722 -731.
  • 9Boston PF, Jackson P, Thompson ILl. Human 14-3-3 protein: radioimmunoassay, tissue distribution, and cerebrospinal fluid levels in patients with neurological disorders [ J]. J Neurochem, 1982, 38 (5) :1475 - 1482.
  • 10Boston PF, Jackson P, Kynoch PA, et al. Purification, properties,and immunohistochemical localisation of human brain 14-3-3 protein[J]. J Neurochem, 1982, 38(5): 1466-1474.

二级参考文献14

共引文献5

同被引文献41

  • 1苏红英,张白凌,陈余朋,高凌云,高美钦.恶性黑色素瘤细胞角蛋白的表达[J].福建医科大学学报,2006,40(6):553-555. 被引量:3
  • 2钟政荣,沈继龙,胡元生,李小月,胡建国,李兴武,王凤超.乳腺癌14-3-3 sigma基因表达及其临床意义[J].临床检验杂志,2007,25(2):93-95. 被引量:1
  • 3Cao WD,Zhang X,Zhang JN,et al.Immunocytochemical detection of 14-3-3 in primary nervous system tumors[J].J Nourouncol,2006,77(2):125-130.
  • 4Yang X,Cao W,Lin H,et al.Isoform-specific expression of 14-3-3 proteins in human astrocytoma[J].J Neurol Sci,2009,276(1-2):54-59.
  • 5Li Z,Zhao J,Du Y,et al.Down-regulation d 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation[J].Proc Natl Acad Sci USA,2008,105(1):162-167.
  • 6Fire A,Xu S,Montgomery MK,et al.Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans[J].Nature,1998,391(6669):806-811.
  • 7Meister G,Tuschl T.Mechanisms of gene silencing by double-stranded RNA[J].Nature,2004,431(7006):343-349.
  • 8Hannon GJ,Rossi JJ.Unlocking the potential of the human genome with RNA interference[J].Nature,2004,431(7006):371-378.
  • 9van Hemert MJ, Steensma HY, van Heusden GP. 14-3-3proteins: key regulators of cell division, signalling and apoptosis [J]. Bioessays, 2001, 23(10) : 936 -946.
  • 10Baxter HC, Fraser JR, Liu WG, et al. Specific 14-3-3 isoform detection and immunolocalization in prion diseases [ J ]. Biochem Soc Trans, 2002, 30(4) : 387 -391.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部